MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PHAT made $49,504,000 in revenue. -$29,973,000 in net income. Net profit margin of -60.55%.

Income Overview

Revenue
$49,504,000
Net Income
-$29,973,000
Net Profit Margin
-60.55%
EPS
-$0.41
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Product revenue, net
49,504,000 39,503,000 28,519,000 12,966,666.667
Cost of revenue
6,190,000 5,038,000 3,724,000 1,872,333.333
Gross profit
43,314,000 34,465,000 24,795,000 11,094,333.333
Research and development
7,027,000 9,076,000 9,184,000 8,463,000
Selling, general and administrative
51,558,000 85,313,000 94,474,000 71,521,666.667
Total operating expenses
58,585,000 94,389,000 103,658,000 79,984,666.667
Loss from operations
-15,271,000 -59,924,000 -78,863,000 -68,890,333.333
Interest income
1,413,000 1,787,000 2,640,000 3,815,666.667
Interest expense
16,108,000 17,518,000 18,071,000 17,841,666.667
Other expense, net
-7,000 -155,000 -22,000 0
Total other expense
-14,702,000 -15,886,000 -15,453,000 -14,026,000
Net loss and comprehensive loss
-29,973,000 -75,810,000 -94,316,000 -82,916,333.333
Net loss per share, basic
-0.41 -1.05 -1.31 -1.323
Net loss per share, diluted
-0.41 -1.05 -1.31 -1.323
Weighted-average shares of common stock outstanding, basic
73,396,435 72,466,203 71,969,411 -483,879
Weighted-average shares of common stock outstanding, diluted
73,396,435 72,466,203 71,969,411 -483,879
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss andcomprehensive loss-$29,973,000 Product revenue, net$49,504,000 Total other expense-$14,702,000 Loss from operations-$15,271,000 Interest income$1,413,000 Gross profit$43,314,000 Cost of revenue$6,190,000 Other expense, net-$7,000 Interest expense$16,108,000 Total operatingexpenses$58,585,000 Selling, general andadministrative$51,558,000 Research and development$7,027,000

Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals, Inc. (PHAT)